Tag: targeted therapy market growth

  • Top Growth Trends in the Targeted Therapy Market: Insights into Market Size and Opportunities for 2025-2034

    Top Growth Trends in the Targeted Therapy Market: Insights into Market Size and Opportunities for 2025-2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Are the Primary Drivers Supporting the Market Growth of theTargeted Therapy Market?

    The targeted therapy market is predicted to expand due to the growing incidence of cancer. Cancer describes conditions characterized by abnormal cells that can both invade surrounding tissues and multiply unchecked. Targeted therapy is capable of disabling the signals that stimulate cancer cell growth or prompting these cells to self-terminate. This therapy uses drugs to specifically target genes and proteins responsible for cancer cell proliferation and sustainability, thereby elevating its demand. For example, the American Cancer Society, a US-nonprofit cancer advocacy group, reported in January 2024 that the number of cancer cases rose to 2,001,140 compared to 1,958,310 in 2023, a growth of 2.19%. Consequently, the escalating prevalence of cancer is expected to fuel the growth of the targeted therapy market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    How Will the Growth Rate of theTargeted Therapy Market Impact Industry Trends by 2034?

    The size of the targeted therapy market has expanded significantly in the previous years. Its growth is projected to increase from $103.84 billion in 2024 to $111.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. Key factors contributing to the growth in the past period encompass progress made in molecular biology, a rising number of cancer cases, a trend towards personalized medicine, and the approval and support provided by FDA regulations.

    The market size for targeted therapy is projected to experience substantial growth in the coming years, with the expected value reaching $151.48 billion in 2029 and a compound annual growth rate (CAGR) of 8.0%. This predicted growth within the given timeframe can be traced back to factors such as increased oncology research, the growing need for precision medicine, the development of immunotherapies, heightened investment in biopharmaceuticals, and patient consciousness and advocacy. Notable trends for the forecast period encompass the incorporation of artificial intelligence (AI) in drug discovery, patient advocacy and participation in treatment choices, the growth of companion diagnostics, regulatory backing for fast-track approvals, and increased investment in biotech and pharmaceuticals.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

    What Are the Latest Innovations Influencing theTargeted Therapy Market?

    Major companies in the targeted therapy market are prioritizing the development of novel technological solutions to enhance their market standings. For example, in March 2022, Novartis AG, a multinational pharmaceutical corporation based in Switzerland, initiated the launch of Pluvicto, a product approved by the US Food and Drug Administration (FDA). This product, Pluvicto, is the first FDA-sanctioned targeted radioligand therapy (RLT) for patients eligible with mCRPC. It marries a therapeutic radioisotope with a targeted chemical, forming a type of cancer therapy where a targeting chemical is paired with a therapeutic radioisotope. Pluvicto adheres to target cells in the bloodstream, including prostate cancer cells that express the PSMA transmembrane protein. Upon binding, the energy emissions from the radioisotope harm the target cells and other nearby cells, restricting their replication capabilities and/or causing cell death.

    Who Are the Major Industry Players Accelerating Growth in theTargeted Therapy Market?

    Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Which Primary Segments of the Targeted Therapy Market Are Driving Growth and Industry Transformations?

    The targeted therapy market covered in this report is segmented –

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Subsegments:

    1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

    2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theTargeted Therapy Market?# Market?

    North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Targeted Therapy Market 2025, By The Business Research Company:

    Tank Wagons Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/tank-wagons-global-market-report

    Boiler, Tank, And Shipping Container Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

    ISO Tank Container Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/iso-tank-container-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis of the Targeted Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Comprehensive Analysis of the Targeted Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the targeted therapy market grown in recent years?

    The market size for targeted therapy has experienced significant growth in the past few years. It is projected to expand from $103.84 billion in 2024 to $111.47 billion in 2025, signifying a compound annual growth rate (CAGR) of 7.3%. Several factors have contributed to this growth during the historical period, including advances in molecular biology, rising incidences of cancer, a shift towards personalized medicine, support from FDA approvals, and regulatory endorsements.

    How is the targeted therapy market size expected to evolve during the forecast period?

    Get your targeted therapy market report here!

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Which key drivers are propelling the targeted therapy market’s growth?

    The escalating numbers of cancer instances are anticipated to drive the expansion of the targeted therapy market in the future. Cancer is a condition characterized by rogue cells that can invade surrounding tissues and proliferate uncontrollably. By interrupting the signals that promote the multiplication of cancer cells or inducing the cancer cells to self-annihilate, targeted therapy aids. This kind of therapy uses drugs engineered specifically to act upon genes and proteins which enable cancer cells to thrive and endure, thus boosting its demand. For example, data from the American Cancer Society, a US-based charity dedicated to cancer advocacy, showed in January 2024, the cancer case count had risen to 2,001,140 from 1,958,310 in 2023, a surge of 2.19%. Therefore, the rising frequency of cancer will be a principal driver for the expansion of the targeted therapy market.

    What are the market segments in the targeted therapy industry?

    The targeted therapy market covered in this report is segmented –

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Subsegments:

    1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

    2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    Which leading companies are shaping the growth of the targeted therapy market?

    Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

    What key trends are currently impacting the targeted therapy market’s development?

    Leading organizations in the targeted therapy market, such as Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., and AbbVie Inc., are driving significant operations. Other key players include Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, and AstraZeneca. Furthermore, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., and Genmab A/S are also significant contributors. Companies like Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., and Illumina Inc. are key players, along with Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., and Daiichi Sankyo Company Limited.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

    Which geographic areas are influencing the growth of the targeted therapy market?

    North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Culture Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Cellular Telephones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Unlocking the Future of the Targeted Therapy Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Unlocking the Future of the Targeted Therapy Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    Analyzing the Growth Rate of the Targeted Therapy Market: What’s the Expected CAGR for the Next Decade?

    The market size for targeted therapy has been expanding robustly over the past few years. It’s estimated to grow from $103.84 billion in 2024 to $111.47 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.3%. The notable growth in the past can be credited to advancements in the field of molecular biology, rise in cancer prevalence, the growing trend of personalised medicine as well as regulatory support and approvals from the FDA.

    The market size for targeted therapy is predicted to experience significant growth in the coming years, expanding to $151.48 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. This expected growth during the forecast period can be linked to factors such as increased research in oncology, growing demand for precision medicine, the advent of immunotherapies, surge in biopharmaceutical investments, and heightened patient awareness and advocacy. The key trends projected for this period involve harnessing artificial intelligence in drug research, greater patient advocacy and participation in treatment choices, the broadening of companion diagnostics, regulatory backing for speedy approvals, and a rise in investment in biotechnology and pharmaceutical industries.

    Which Major Market Drivers Are Expected to Boost the Targeted Therapy Market’s Growth Potential?

    The targeted therapy market is predicted to expand due to the rising incidence of cancer. Cancer is characterized by abnormal cells that multiply uncontrollably and can invade adjacent tissues. Targeted therapy can inhibit the signals that stimulate cancer cell growth or trigger self-destruction in these cells. This type of therapy utilizes drugs to specifically target the genes and proteins facilitating cancer cell growth and survival, thereby heightening its demand. For example, the American Cancer Society, a nonprofit cancer advocacy organization in the US, reported that the number of cancer cases rose to 2,001,140 in January 2024 from 1,958,310 in 2023, an increase of 2.19%. Thus, the escalating prevalence of cancer is anticipated to fuel the growth of the targeted therapy market.

    Explore Comprehensive Insights Into The Global Targeted Therapy Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    What Are the Leading Organizations Impacting the Targeted Therapy Market’s Growth?

    Major companies operating in the targeted therapy market include:

    • Pfizer Inc.

    • Johnson & Johnson

    • F. Hoffmann-La Roche Ltd

    • Merck & Co Inc.

    • AbbVie Inc.

    What Are the Most Prominent Trends Driving Change in the Targeted Therapy Market?

    Leading companies in the targeted therapy market are executing strategies of introducing novel technological solutions to consolidate their presence in the industry. An example of this strategy was observed in March 2022 when Novartis AG, a Swiss multinational pharmaceutical firm, released Pluvicto after receiving approval from the US Food and Drug Administration (FDA). Pluvicto, the inaugural targeted radioligand therapy (RLT) approved by the FDA for apt patients with mCRPC, is a category of targeted cancer therapy that merges a therapeutic radioisotope with a chemical target, known as a radioactive particle. Pluvicto bonds with target cells in the bloodstream, including those prostate cancer cells that showcase the PSMA transmembrane protein. Post bonding, the energy releases from the radioisotope damages the target cells and neighboring cells in the area, thereby inhibiting their ability to replicate and potentially leading to cellular death.

    Secure Your Global Targeted Therapy Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Which Segments Play a Crucial Role in the Expansion of the Targeted Therapy Market?

    The targeted therapy market covered in this report is segmented –

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Subsegments:

    1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

    2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

    What Regions Are Leading the Charge in the Targeted Therapy Market?

    North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Does the Definition of the Targeted Therapy Market Include?

    Targeted therapy refers to a kind of cancer treatment that employs medications or other chemicals to attack particular molecules required for the survival and spread of cancer cells. It uses drugs to target specific genes and proteins that help cancer cells survive and grow.

    Browse Through More Similar Reports By The Business Research Company:

    Cell Culture Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Cellular Telephones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Targeted Therapy Market Growth Potential: Key Insights for 2024-2033

    Targeted Therapy Market Growth Potential: Key Insights for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Will the Targeted Therapy Market Grow from 2024 to 2033?

    The market size for targeted therapy has significantly increased in the recent past. It is forecasted to expand from $97.72 billion in 2023 to $105.06 billion in 2024, maintaining a steady compound annual growth rate (CAGR) of 7.5%. This substantial growth in the past years can be owed to the progression made in molecular biology, rising instances of cancer, the trend towards personalized medicine, FDA’s endorsement, and regulatory support.

    In the coming years, the market size for targeted therapy is predicted to exhibit robust growth, escalating to $140.77 billion in 2028 with a 7.6% compound annual growth rate (CAGR). The increased growth projected for this period can be credited to the progression in oncology research, the surge in demand for precision medicine, the advent of immunotherapies, increased funding in biopharmaceuticals, and heightened patient awareness and advocacy. During this forecast period, significant trends will consist of the incorporation of artificial intelligence (AI) in drug discovery, patient advocacy and participation in treatment choices, the extension of companion diagnostics, regulatory encouragement for accelerated approvals, and heightened investment in biotechnology and pharma.

    Claim Your Free Sample of the Global Targeted Therapy Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

    What Aspects Are Influencing the Growth Rate of the targeted therapy Market?

    The escalating incidence of cancer is forecasted to stimulate the growth of the targeted therapy market. Cancer, described as a condition where errant cells proliferate without control and invade neighboring tissues, is on the rise. Targeted therapy interrupts the signals that incite the growth of cancer cells or commands the cancer cells to eliminate themselves. This therapy utilizes medication to specifically target the genes and proteins that foster the growth and survival of cancer cells, which consequently heightens its demand. For example, in September 2021, according to the National Cancer Institute, a US government organization that is a part of the National Institutes of Health, it was reported that 1,806,590 new cancer cases were logged, pointing to a 43% increase from the previous year. Hence, the rising prevalence of cancer is propelling the growth of the targeted therapy market.

    What Are the Critical Segments of the Targeted Therapy Market?

    1) By Type: Small Molecule Medicines, Monoclonal Antibodies

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    What Trends Are Redefining Consumer Expectations in the Targeted Therapy Market?

    Order Now for Fast Delivery of Your Targeted Therapy Market Report!

    https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    What Are the Leading Regions in the Targeted Therapy Market Expansion?

    North America was the largest region in the targeted therapy market in 2023. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Targeted Therapy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the targeted therapy market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Targeted Therapy Market Include

    1. Targeted Therapy Market Executive Summary

    2. Targeted Therapy Market Segments

    3. Targeted Therapy Market Size And Template Market Growth Rate

    4. Key Targeted Therapy Market Trends

    5. Major Targeted Therapy Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Targeted Therapy Market

    26. Top Targeted Therapy Companies

    27. Targeted Therapy Market Opportunities And Strategies

    28. Targeted Therapy Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Cellular Telephones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

    Cell and Gene Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

    Cell Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Targeted Therapy Market 2024

    5 Key Insights On The Targeted Therapy Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Targeted Therapy Global Market Report 2024, the targeted therapy market is expected to show significant growth in the forecast period.

    Strong Recent Growth in Targeted Therapy Market

    The targeted therapy market has experienced significant growth in recent years.

    • Market Size Growth: The market size increased from $97.72 billion in 2023 to $105.06 billion in 2024, reflecting a compound annual growth rate (CAGR) of 7.5%.
    • Contributing Factors: Advancements in molecular biology, rising cancer incidence, personalized medicine trends, FDA approvals, and regulatory support have driven this growth.

    Projected Growth and Key Drivers

    Looking ahead, the targeted therapy market is set to continue its robust growth.

    • Future Market Size: Expected to reach $140.77 billion by 2028, with a CAGR of 7.6%.
    • Growth Drivers: Expanding oncology research, rising demand for precision medicine, emergence of immunotherapies, increasing investment in biopharmaceuticals, and heightened patient awareness and advocacy.

    Major Trends Shaping the Future

    Several key trends are anticipated to shape the targeted therapy market in the coming years.

    • AI Integration: Incorporation of artificial intelligence in drug discovery.
    • Patient Advocacy: Increased patient involvement in treatment decisions.
    • Companion Diagnostics: Expansion in the use of companion diagnostics.
    • Regulatory Support: Enhanced regulatory support for expedited approvals.
    • Investment in Biotechnology: Rising investment in biotechnology and pharmaceuticals.

    View More On The Targeted Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

    Rising Cancer Prevalence Fuels Surge in Demand

    The growing prevalence of cancer is a significant factor propelling the targeted therapy market.

    • Cancer Statistics: According to the National Cancer Institute, there were 1,806,590 new cancer cases registered in September 2021, a 43% increase from the previous year.
    • Therapy Benefits: Targeted therapy disables signals that promote cancer cell growth or triggers cancer cell self-destruction, increasing its demand.

    Leading Companies in the Market

    Major players in the targeted therapy market include:

    • Pfizer Inc.
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co Inc.
    • AbbVie Inc.
    • Bayer AG
    • Novartis AG
    • Sanofi SA
    • Gilead Sciences Inc.
    • Seagen Inc.
    • Exelixis Inc.
    • Seattle Genetics Inc.
    • Genentech Inc.
    • Daiichi Sankyo Company Limited
    • ChemGenex Pharmaceuticals Ltd

    Advanced Targeted Therapy Market with FDA Approval

    Companies in the targeted therapy market are focusing on developing advanced technological solutions to strengthen their market position.

    • Novartis AG: In March 2022, Novartis launched Pluvicto, the first FDA-approved targeted radioligand therapy for eligible patients with mCRPC. This therapy combines a therapeutic radioisotope with a targeting chemical to attack cancer cells effectively.

    Strategic Acquisitions Strengthen Precision Oncology Portfolios

    Strategic acquisitions are also playing a crucial role in expanding the capabilities and offerings of leading companies in the market.

    • Bristol Myers Squibb: Acquired Turning Point Therapeutics in August 2022. This acquisition enhances Bristol Myers Squibb’s ability to address non-small cell lung cancer with ROS1-positive mutations and provides access to a pipeline of experimental drugs targeting oncogenesis-related mutations.

    Market Segmentation

    The targeted therapy market is segmented into:

    • By Type: Small Molecule Medicines, Monoclonal Antibodies
    • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
    • By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

    Regional Insights

    • North America: The largest region in the targeted therapy market in 2023, driven by advanced healthcare infrastructure, significant investment in research, and high adoption of new technologies.

    The targeted therapy market is on a trajectory of continued expansion, driven by technological advancements, strategic acquisitions, and a growing focus on personalized medicine. With ongoing research and development, the market is poised for significant innovations and improvements in cancer treatment.

    Request A Sample Of The Global Targeted Therapy Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9129&type=smp